Congenica is a leading provider of genomic analysis software and services who have developed the gold-standard clinical genomics analysis platform Sapientia. Based in Cambridge, UK, and born out of pioneering research from the Sanger Institute, Congenica aims to revolutionize personalized patient care through accurate diagnoses, curation of evolving knowledge bases and support in clinical trials and drug development.
Congenica’s world-class team of experts have gathered together, in a single secured platform, all the resources necessary to enable clinicians and scientists to make informed medical decisions. Validated by Genomics England for the 100K Genomes Project, Congenica are empowering doctors around the world to diagnose the un-diagnosable.
Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project06 Sep 2017 CongenicaCongenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portu ...